94 related articles for article (PubMed ID: 2164458)
1. Low sodium intake corrects abnormality in beta-receptor-mediated arterial vasodilation in patients with hypertension: correlation with beta-receptor function in vitro.
Naslund T; Silberstein DJ; Merrell WJ; Nadeau JH; Wood AJ
Clin Pharmacol Ther; 1990 Jul; 48(1):87-95. PubMed ID: 2164458
[TBL] [Abstract][Full Text] [Related]
2. Defective venous beta-adrenergic response in borderline hypertensive subjects is corrected by a low sodium diet.
Feldman RD
J Clin Invest; 1990 Mar; 85(3):647-52. PubMed ID: 2155921
[TBL] [Abstract][Full Text] [Related]
3. Low sodium diet corrects the defect in lymphocyte beta-adrenergic responsiveness in hypertensive subjects.
Feldman RD; Lawton WJ; McArdle WL
J Clin Invest; 1987 Jan; 79(1):290-4. PubMed ID: 3025262
[TBL] [Abstract][Full Text] [Related]
4. Forearm beta adrenergic receptor-mediated vasodilation is impaired, without alteration of forearm norepinephrine spillover, in borderline hypertension.
Stein CM; Nelson R; Deegan R; He H; Wood M; Wood AJ
J Clin Invest; 1995 Jul; 96(1):579-85. PubMed ID: 7615830
[TBL] [Abstract][Full Text] [Related]
5. A low-sodium diet corrects the defect in beta-adrenergic response in older subjects.
Feldman RD
Circulation; 1992 Feb; 85(2):612-8. PubMed ID: 1310451
[TBL] [Abstract][Full Text] [Related]
6. Plasma catecholamines and cardiac, renal and peripheral vascular adrenoceptor-mediated responses in different age groups of normal and hypertensive subjects.
Bühler FR; Kiowski W; van Brummelen P; Amann FW; Bertel O; Landmann R; Lütold BE; Bolli P
Clin Exp Hypertens (1978); 1980; 2(3-4):409-26. PubMed ID: 6253240
[TBL] [Abstract][Full Text] [Related]
7. Estimated affinity of isoproterenol to cardiac chronotropic beta-receptor and of phenylephrine to vasoconstrictive alpha-receptor of the systemic resistance vessels in human borderline hypertension.
Ito H; Tonai N; Hirakawa S
Jpn Circ J; 1983 Feb; 47(2):240-55. PubMed ID: 6298482
[TBL] [Abstract][Full Text] [Related]
8. Adrenergic activity and peripheral hemodynamics in relation to sodium sensitivity in patients with essential hypertension.
Koolen MI; van Brummelen P
Hypertension; 1984; 6(6 Pt 1):820-5. PubMed ID: 6519741
[TBL] [Abstract][Full Text] [Related]
9. Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm.
Lembo G; Iaccarino G; Vecchione C; Barbato E; Izzo R; Fontana D; Trimarco B
J Clin Invest; 1997 Oct; 100(8):2007-14. PubMed ID: 9329964
[TBL] [Abstract][Full Text] [Related]
10. Altered vascular beta adrenoceptor-mediated relaxation in deoxycorticosterone-salt hypertensive rats.
Fujimoto S; Dohi Y; Aoki K; Matsuda T
J Pharmacol Exp Ther; 1988 Feb; 244(2):716-23. PubMed ID: 2831351
[TBL] [Abstract][Full Text] [Related]
11. Lack of correlation between arterial and venous beta-adrenergic receptor sensitivity.
Stein CM; Deegan R; Wood AJ
Hypertension; 1997 Jun; 29(6):1273-7. PubMed ID: 9180628
[TBL] [Abstract][Full Text] [Related]
12. Beta-adrenergic receptor-mediated release of norepinephrine in the human forearm.
Stein M; Deegan R; He H; Wood AJ
Clin Pharmacol Ther; 1993 Jul; 54(1):58-64. PubMed ID: 8392457
[TBL] [Abstract][Full Text] [Related]
13. Dietary sodium intake modulates systemic but not forearm norepinephrine release.
Stein CM; Nelson R; Brown M; He H; Wood M; Wood AJ
Clin Pharmacol Ther; 1995 Oct; 58(4):425-33. PubMed ID: 7586935
[TBL] [Abstract][Full Text] [Related]
14. Beta-adrenergic receptor alterations in hypertension--physiological and molecular correlates.
Feldman RD
Can J Physiol Pharmacol; 1987 Aug; 65(8):1666-72. PubMed ID: 2825942
[TBL] [Abstract][Full Text] [Related]
15. Adrenaline induces vasoconstriction through post-junctional alpha 2 adrenoceptors and this response is enhanced in patients with essential hypertension.
Bolli P; Erne P; Ji BH; Block LH; Kiowski W; Bühler FR
J Hypertens Suppl; 1984 Dec; 2(3):S115-8. PubMed ID: 6100732
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the lymphocyte adenylate cyclase system by prostaglandin E2 infusions in resistant hypertensive subjects.
Krasnikova T; Minchuna V; Runikhin A; Arabidze G; Mazaev A
Am J Hypertens; 1992 Jun; 5(6 Pt 2):140S-146S. PubMed ID: 1321638
[TBL] [Abstract][Full Text] [Related]
17. Altered beta-receptor control of in situ membrane potential in hypertensive rats.
Stekiel WJ; Contney SJ; Rusch NJ
Hypertension; 1993 Jun; 21(6 Pt 2):1005-9. PubMed ID: 8099344
[TBL] [Abstract][Full Text] [Related]
18. Leukocyte beta-receptor alterations in hypertensive subjects.
Feldman RD; Limbird LE; Nadeau J; Robertson D; Wood AJ
J Clin Invest; 1984 Mar; 73(3):648-53. PubMed ID: 6323524
[TBL] [Abstract][Full Text] [Related]
19. Beta(2)-adrenoceptor polymorphism determines vascular reactivity in humans.
Cockcroft JR; Gazis AG; Cross DJ; Wheatley A; Dewar J; Hall IP; Noon JP
Hypertension; 2000 Sep; 36(3):371-5. PubMed ID: 10988267
[TBL] [Abstract][Full Text] [Related]
20. Tissue-type plasminogen activator release in healthy subjects and hypertensive patients: relationship with beta-adrenergic receptors and the nitric oxide pathway.
Giannarelli C; Virdis A; De Negri F; Duranti E; Magagna A; Ghiadoni L; Salvetti A; Taddei S
Hypertension; 2008 Aug; 52(2):314-21. PubMed ID: 18574075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
